RSS

TESARO

Biopharmaceutical company, Tesaro, has revealed that the European Commission has approved its monotherapy for the maintenance treatment of women with recurrent ovarian cancer. more

News

Small molecule pharmaceutical development and manufacturing capability and technology platform company, STA Pharmaceutical, has entered into a five-year supply agreement with oncology-focused biopharma company, TESARO. more

News